S. Reim, P. Langer / Tetrahedron Letters 49 (2008) 2329–2332
2331
10. (a) Ahad, A. M.; Goto, Y.; Kiuchi, F.; Tsuda, Y.; Kondo, K.; Sato,
T. Chem. Pharm. Bull. 1991, 39, 1043; (b) Kim, Y.-J.; Nishida, H.;
Pang, C.-H.; Saito, T.; Shinichi, S.; Tonai-Kachi, H.; Yoshikawa, N.;
Vanvolkenburg, M. A.; Parkerf, J. C.; Kojima, Y. J. Antibiot. 2002,
55, 121; Longissiminone B: (c) Choudhary, M. I.; Azizuddin, M.;
Jalil, S.; Atta-ur-Rahman Phytochemistry 2005, 66, 2346; Chloro-
isosulochrin: (d) Shimada, A.; Takahashi, I.; Kawano, T.; Kimura, Y.
Z. Naturforsch., B: Chem. Sci. 2001, 56, 797; Pestalone: (e) Cueto, M.;
Jensen, P. R.; Kauffman, C.; Fenical, W.; Lobkovsky, E.; Clardy, J. J.
Nat. Prod. 2001, 64, 1444; (f) Iijima, D.; Tanaka, D.; Hamada, M.;
Ogamino, T.; Ishikawa, Y.; Nishiyama, S. Tetrahedron Lett. 2004, 45,
5469; Methyl chloroasterrate: (g) Hargreaves, J.; Park, J.-O.; Ghisal-
berti, E. L.; Sivasithamparam, K.; Skelton, B. W.; White, A. H. J.
Nat. Prod. 2002, 65, 7; (h) Lee, H. J.; Lee, J. H.; Hwang, B. Y.; Kim,
H. S.; Lee, J. J. J. Antibiot. 2002, 55, 552.
11. Falconensin B: Itabashi, T.; Nozawa, K.; Miyaji, M.; Udagawa, S.-i.;
Nakajima, S.; Kawai, K.-i. Chem. Pharm. Bull. 1992, 40, 3142.
12. Chromones: Kawamura, N.; Sawa, R.; Takahashi, Y.; Issiki, K.;
Sawa, T. J. Antibiot. 1995, 48, 435.
13. Hoeller, U.; Koening, G.; Wright, A. D. J. Nat. Prod. 1999, 62, 114.
14. (a) Chan, T.-H.; Brownbridge, P. J. Am. Chem. Soc. 1980, 102, 3534;
(b) Brownbridge, P.; Chan, T.-H.; Brook, M. A.; Kang, G. J. Can. J.
Chem. 1983, 61, 688.
Me3SiO OSiMe3
Cl
Cl
OMe
3
i
HO
OMe
O
Cl
O
O
O
+
Cl
O
15
14
Scheme 6. Synthesis of 15. Reagents and conditions: (i) Me3SiOTf
(0.3 equiv), CH2Cl2, ꢀ78 ? 20 °C, 20 h.
The formation of this product can be explained by the
attack of carbon atom C-4 of 3 onto 14 and subsequent
regioselective cyclization via the neighboured oxygen atom
of 3.23 The exocyclic double bond was formed with high
Z-diastereoselectivity (due to the steric influence of the
chlorine atom).
In conclusion, a variety of highly substituted chlorinated
arenes and hetarenes were regioselectively prepared by one-
pot cyclizations of the first 4-chloro-1,3-bis(trimethylsilyl-
oxy)-1,3-butadiene. The products are not readily available
by other methods.
15. For a review of 1,3-bis(trimethylsilyloxy)-1,3-dienes in general, see:
Langer, P. Synthesis 2002, 441.
16. For a review of [3+3] cyclizations, see: Feist, H.; Langer, P. Synthesis
2007, 327.
17. (a) Ruegg, R.; Lindlar, H.; Montavon, M.; Savey, G.; Schaeren, S. T.;
Schwieter, U.; Isler, O. Helv. Chim. Acta 1959, 42, 844; (b) Ruegg, R.;
Lindlar, H.; Montavon, M.; Savey, G.; Schaeren, S. T.; Schwieter, U.;
Isler, O. Helv. Chim. Acta 1959, 42, 859.
Acknowledgement
Financial support from the State of Mecklenburg-
Vorpommern is gratefully acknowledged.
18. Mamat, C.; Buttner, S.; Trabhardt, T.; Fischer, C.; Langer, P. J. Org.
¨
Chem. 2007, 72, 6273.
19. General procedure for the synthesis of salicylates 5 and 7: To a stirred
CH2Cl2 solution of 3 (1.0 equiv) was added 1,1,3,3-tetraalkoxypro-
pane 4a–e (0.5 equiv) or 3-(silyloxy)alk-2-en-1-one 6a–g (1.0 equiv) at
ꢀ78 °C under argon atmosphere. Subsequently, TiCl4 (1.0 equiv) was
dropwise added. The temperature of the reaction mixture was allowed
to rise to 20 °C during 20 h. The solution was poured into an aqueous
solution of HCl (10%). The organic layer was separated and the
aqueous layer was repeatedly extracted with CH2Cl2. The combined
organic layers were dried (Na2SO4) and filtered. The filtrate was
concentrated in vacuo and the residue was purified by chromato-
graphy (silica gel, n-heptane/EtOAc) to give salicylates 5 or 7. Methyl
3-chloro-2-hydroxybenzoate (5a): Starting with 3 (0.590 g, 2.0 mmol),
1,1,3,3-tetramethoxypropane (4a) (0.164 g, 1.0 mmol) and TiCl4
(0.22 mL, 2.0 mmol) in CH2Cl2 (2 mL), 5a was isolated after column
chromatography (silica gel, n-heptane/EtOAc = 20:1) as a yellow oil
(0.074 g, 36%). 1H NMR (300 MHz, CDCl3): d = 3.96 (s, 3H, OCH3),
6.83 (t, 3J = 8.0 Hz, 1H, CH), 7.54 (dd, 2J = 1.7 Hz, 3J = 6.3 Hz, 1H,
CH), 7.76 (dd, 2J = 1.7 Hz, 3J = 6.3 Hz, 1H, CH), 11.33 (s, 1H, OH).
13C NMR(75 MHz, CDCl3): d = 52.7 (OCH3), 113.6 (CAr), 119.2
(CH), 122.2 (CAr), 128.4, 135.8 (CH), 157.3 (COH), 170.3 (COOCH3).
IR (ATR, cmꢀ1): ~m ¼ 3090 (w), 2955 (w), 2926 (w), 2853 (w), 1732 (w),
1675 (s), 1607 (m), 1438 (s), 1322 (s), 1282 (m), 1252 (s), 1197 (s), 1176
(s), 1151 (s), 1073 (m). MS (GC–MS, 70 eV): m/z (%) = 188 ([M]+,
References and notes
1. Ro¨mpp Lexikon Naturstoffe; Steglich, W., Fugmann, B., Lang-
Fugmann, S., Eds.; Thieme: Stuttgart, 1997.
2. Metal-Catalyzed Cross-Coupling Reactions; de Meijere, A., Diederich,
F., Eds.; Wiley-VCH: Weinheim, 2004.
3. Dihydronidulin: Finlay-Jones, P. F.; Sala, T.; Sargent, M. V. J. Chem.
Soc., Perkin Trans. 1 1981, 874.
4. Griseofulvin: (a) Osborne, C. S.; Leitner, I.; Hofbauer, B.; Fielding,
C. A.; Favre, B.; Ryder, N. S. Antimicrob. Agents Chemother. 2006,
50, 2234; (b) Takano, R.; Sugano, K.; Higashida, A.; Hayashi, Y.;
Machida, M.; Aso, Y.; Yamashita, S. Pharm. Res. 2006, 23, 1144; (c)
Xue, C.; Li, T.; Deng, Z.; Fu, H.; Lin, W. Pharmazie 2006, 61, 1041;
(d) Phelps, J. B.; Hoffman, W. P.; Lee, C.; Murphy, G. P.; Garriott,
M. L. Mutat. Res. 2004, 561, 153; (e) Rosefort, C.; Fauth, E.; Zankl,
H. Mutagenesis 2004, 19, 277; (f) Kinobe, R. T.; Dercho, R. A.;
Vlahakis, J. Z.; Brien, J. F.; Szarek, W. A.; Nakatsu, K. J. Pharmacol.
Exp. Ther. 2006, 319, 277; (g) Albaugh, D.; Albert, G.; Bradford, P.;
Cotter, V.; Froyd, J. J. Antibiot. 1998, 51, 317.
5. Epigriseofulvin: Namikoshi, M.; Kobayashi, H.; Yoshimoto, T.;
Meguro, S.; Akano, K. Chem. Pharm. Bull. 2000, 48, 1452.
6. Belofsky, G. N.; Gloer, K. B.; Gloer, J. B.; Wicklow, D. T.; Dowd, P.
F. J. Nat. Prod. 1998, 61, 1115.
7. Geodin: (a) Katoh, T.; Ohmori, O. Tetrahedron Lett. 2000, 41, 465;
(b) Fujii, I.; Iijima, H.; Ebizuka, Y.; Sankawa, U. Chem. Pharm. Bull.
1983, 31, 337; (c) Katoh, T.; Ohmori, O.; Iwasaki, K.; Inoue, M.
Tetrahedron 2002, 58, 1289.
[
C
37Cl], 11), 186 ([M]+, [35Cl], 33), 156 (34), 154 (100). Anal. Calcd for
10H11ClO3 (214.65): C, 55.96; H, 5.17. Found: C, 55.72; H, 5.32.
Methyl 3-chloro-2-hydroxy-4,5,6-trimethylbenzoate (7a): Starting with
3 (0.442 g, 1.5 mmol), 3-methyl-4-(trimethylsilyloxy)pent-3-en-2-one
(6a) (0.279 g, 1.5 mmol) and TiCl4 (0.16 mL, 1.5 mmol) in CH2Cl2
(3 mL), 7a was isolated after column chromatography (silica gel,
n-heptane/EtOAc = 20:1) as a yellow oil (0.129 g, 38%). 1H NMR
(300 MHz, CDCl3): d = 2.17 (s, 3H, CH3), 2.38 (s, 6H, CH3), 3.95 (s,
3H, OCH3), 10.58 (s, 1H, OH). 13C NMR (75 MHz, CDCl3):
d = 16.4, 18.0, 18.9 (CH3), 52.3 (OCH3), 113.0, 119.9, 128.0, 135.8,
140.7 (CAr), 153.9 (COH), 171.5 (COOCH3). IR (ATR, cmꢀ1):
~m ¼ 2957 (w), 2922 (w), 2851 (w), 1732 (m), 1660 (m), 1593 (w), 1496
8. Geodinhydrate methyl ester: Hargreaves, J.; Park, J.-o.; Ghisalberti,
E. L.; Sivasithamparam, K.; Skelton, B. W.; White, A. H. J. Nat.
Prod. 2002, 65, 7.
9. 7-Chloro-1-O-methylemodin: (a) Cohen, P. A.; Towers, G. H. N.
Phytochemistry 1996, 42, 1325; (b) Shu, Y.-Z.; Arcuri, M.; Kozlowski,
M. R.; Wang, R. R.; Lam, K. S. J. Antibiot. 1994, 47, 1328; (c) Cohen,
P. A.; Hudson, J. B.; Towers, G. H. N. Experientia 1996, 52, 180.